Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 6
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Wang, Kai Chen, Songhua Wang, Xiaomeng Zhong, Jieming Wang, Xinting Huai, Pengcheng Wu, Limin Wang, Lixia Jiang, Shiwen Li, Jun Peng, Ying Yao, Hongyan and Ma, Wei 2014. Factors Contributing to the High Prevalence of Multidrug-Resistant Tuberculosis Among Previously Treated Patients: A Case–Control Study from China. Microbial Drug Resistance, Vol. 20, Issue. 4, p. 294.

    Elkomy, Howida Awad, Mohamed El-Shora, Ashraf and Elsherbeni, Badawy 2013. Assessment of the efficacy of Directly Observed Treatment with short course (DOTS) for pulmonary tuberculosis in Sharkia governorate. Egyptian Journal of Chest Diseases and Tuberculosis, Vol. 62, Issue. 2, p. 257.

    Thongraung, Wilawan Sittidach, Maneerat Khwansuwan, Panatda Sariyasuntorn, Kanitha and Wongsampan, Sirinart 2012. Evaluation of the physicians' approach to the diagnosis and treatment of patients with antituberculosis drug-induced hepatotoxicity. Journal of Evaluation in Clinical Practice, Vol. 18, Issue. 6, p. 1119.

    Daniel, Olusoji and Osman, Eltayeb 2011. Prevalence and risk factors associated with drug resistant TB in South West, Nigeria. Asian Pacific Journal of Tropical Medicine, Vol. 4, Issue. 2, p. 148.

    Melzer, Mark Gupta, Nidhi Petersen, Irene Cook, Sue and Hall, Bridget 2010. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK. International Journal of Infectious Diseases, Vol. 14, Issue. 8, p. e717.

    Chakrabarti, Biswajit and Davies, Peter DO 2007. Key issues in multidrug-resistant tuberculosis. Future Microbiology, Vol. 2, Issue. 1, p. 51.


Risk factors for drug resistant tuberculosis in Leicestershire – poor adherence to treatment remains an important cause of resistance

  • A. J. PRITCHARD (a1), A. C. HAYWARD (a2), P. N. MONK (a3) and K. R. NEAL (a4)
  • DOI:
  • Published online: 01 June 2003

In the light of rising numbers of tuberculosis (TB) cases in the United Kingdom, the problem of anti-tubercular drug resistance remains a significant concern. Drug resistant TB cases are more difficult and costly to treat, and require appropriate treatment and control mechanisms. This matched case control study aimed to investigate risk factors for resistance in Leicestershire, using data for laboratory isolates of Mycobacterium tuberculosis identified from 1993 to 1998. Each case, defined as culture positive laboratory isolates resistant to at least one first-line drug, was matched to four fully sensitive controls on age, sex and ethnic group. Twenty-three cases and 81 controls were included in the analysis. Drug resistance in Leicestershire was found to be associated with poor adherence to treatment (OR 4·8, 95% CI 1·6–14·4, P=0·005) and with previous TB (OR 3·7, 95% CI 1·2–11·8, P=0·022). These findings emphasize the need to provide support to patients taking treatment in order to maximize adherence.

Corresponding author
Author for correspondence.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *